Multivalue ethical framework for fair global allocation of a COVID-19 vaccine.
J Med Ethics
; 46(8): 499-501, 2020 08.
Article
en En
| MEDLINE
| ID: mdl-32532826
ABSTRACT
The urgent drive for vaccine development in the midst of the current COVID-19 pandemic has prompted public and private organisations to invest heavily in research and development of a COVID-19 vaccine. Organisations globally have affirmed the commitment of fair global access, but the means by which a successful vaccine can be mass produced and equitably distributed remains notably unanswered. Barriers for low-income countries include the inability to afford vaccines as well as inadequate resources to vaccinate, barriers that are exacerbated during a pandemic. Fair distribution of a pandemic vaccine is unlikely without a solid ethical framework for allocation. This piece analyses four allocation paradigms ability to develop or purchase; reciprocity; ability to implement; and distributive justice, and synthesises their ethical considerations to develop an allocation model to fit the COVID-19 pandemic.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Justicia Social
/
Vacunas Virales
/
Asignación de Recursos para la Atención de Salud
/
Salud Global
/
Infecciones por Coronavirus
/
Equidad en Salud
/
Pandemias
Límite:
Humans
Idioma:
En
Revista:
J Med Ethics
Año:
2020
Tipo del documento:
Article
País de afiliación:
Estados Unidos